Redeemable Preferred Stock and Stockholders' Equity - Additional Information (Detail)
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
Jun. 27, 2022
USD ($)
$ / shares
shares
|
Jun. 10, 2022
shares
|
Feb. 10, 2021
USD ($)
$ / shares
shares
|
Sep. 28, 2020
USD ($)
$ / shares
|
Jul. 23, 2020
USD ($)
$ / shares
shares
|
Jun. 10, 2020
USD ($)
$ / shares
shares
|
Jun. 08, 2020
USD ($)
$ / shares
shares
|
Nov. 14, 2018
USD ($)
d
$ / shares
shares
|
Nov. 09, 2018
USD ($)
d
$ / shares
shares
|
Sep. 27, 2018
USD ($)
$ / shares
|
Mar. 06, 2018
USD ($)
$ / shares
|
Aug. 31, 2020
$ / shares
|
Mar. 31, 2020
USD ($)
$ / shares
shares
|
Nov. 30, 2019
$ / shares
shares
|
Oct. 31, 2019
USD ($)
$ / shares
|
Jun. 30, 2020
$ / shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
shares
|
Dec. 31, 2020
USD ($)
shares
|
Dec. 31, 2019
USD ($)
$ / shares
shares
|
Mar. 01, 2022
$ / shares
|
Feb. 28, 2021
USD ($)
|
May 31, 2019
shares
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 301,782,000
|
$ 293,325,000
|
|
|
|
|
|
Other liabilities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
362,000
|
330,000
|
|
|
|
|
|
Accrued liabilities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,210,000
|
8,276,000
|
|
|
|
$ 600,000
|
|
Allocated Share-based Compensation Expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,303,000
|
1,662,000
|
$ 3,370,000
|
|
|
|
|
Equity raise of gross proceeds | $ |
|
|
$ 14,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value $0.001 per share | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,000
|
$ 6,000
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,723,000
|
6,149,000
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
180,000,000
|
180,000,000
|
|
|
|
|
|
Share price | $ / shares |
|
|
$ 25.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net, shares |
678,745,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants adjusted exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.00
|
|
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,721,000
|
6,147,000
|
|
|
|
|
|
Allocated to the warrants based upon fair values | $ |
|
|
|
|
|
$ 3,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance costs for common stock warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 0
|
1,641,000
|
|
|
|
|
Paid or declared dividends | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
Proceeds from the exercise of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
16,562,000
|
46,000
|
|
|
|
|
Change in fair value of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 0
|
$ (5,850,000)
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111.00%
|
103.00%
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years 1 month 6 days
|
5 years 6 months
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00%
|
0.40%
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,000
|
70,000
|
96,000
|
52,000
|
|
|
|
Other offering expenses | $ |
|
|
|
|
|
|
$ 700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Stock Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,500
|
3,500
|
|
|
|
|
|
Stock options cancelled |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,000,000
|
|
|
|
|
|
|
Stock options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
3,000
|
50,000
|
|
|
|
|
Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted or Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
517,000
|
124,000
|
125,000
|
|
|
|
|
Phantom Share Units (PSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
Other liabilities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
$ 300,000
|
|
|
|
|
|
Allocated Share-based Compensation Expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,000
|
402,000
|
|
|
|
|
|
Stock Appreciation Rights (SARs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
Accrued liabilities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
Allocated Share-based Compensation Expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,000
|
|
|
|
|
|
2002 Stock Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted stock units outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,000
|
|
|
|
|
|
|
Common stock issued pursuant to options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,000
|
|
|
|
|
|
|
Common stock authorized for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,400
|
|
|
|
|
|
|
2018 Long-Term Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in Number of Units Available for Issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
Options and restricted stock units outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000.0
|
|
|
|
|
|
|
Common stock authorized for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
2018 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Employees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Issued AS Part Of Quarter Bonus Program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62,000
|
|
|
|
|
Remaining awards vest based on certain Company performance criteria |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,000
|
|
|
|
|
Units are subject to time-based vesting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
|
|
|
|
Granted or Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
217,000,000
|
121,000
|
104,000
|
|
|
|
|
2018 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted or Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
265,000
|
|
|
|
|
|
|
Stock options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,000
|
|
|
|
|
Deferred Compensation Plan | Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based payment award, number of shares unvested and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
170,000
|
|
|
|
|
|
|
Share based payment award, number of shares vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
86,000
|
|
|
|
|
|
|
Original Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 58.75
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
$ 53.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
|
|
|
|
|
Sep. 27, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock, shares issued and sold |
|
|
|
|
|
|
|
|
14,881
|
|
|
|
|
2,551,000
|
|
|
|
|
|
|
|
|
|
Warrants adjusted strike price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 12.25
|
$ 25.00
|
$ 1.00
|
|
|
|
|
|
|
|
|
Warrant issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
63,779
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
|
|
|
|
|
3.13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
|
|
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
|
|
|
|
|
81.79%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
|
|
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
$ 33.50
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants | $ |
|
|
|
|
|
|
|
|
$ 400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of trading days of average closing price of common stock | d |
|
|
|
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Warrants issued to purchase shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
63,779
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
|
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock |
|
|
|
|
|
|
|
|
372,023
|
|
|
|
487,198
|
|
|
|
|
|
|
|
|
|
|
DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock, shares issued and sold |
|
|
|
|
|
|
|
11,194
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
|
|
|
|
|
3.13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finder's fee | $ |
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 9.50
|
|
|
|
|
$ 15.50
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
|
|
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
|
|
|
|
|
81.79%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
|
|
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
$ 33.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants | $ |
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of trading days of average closing price of common stock | d |
|
|
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock |
|
|
|
|
|
|
|
279,851
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Warrants and DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock Converted to Common stock | $ |
|
|
|
|
|
|
|
$ 5,989,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
$ 54.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,727
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,723,000
|
6,149,000
|
3,908,000
|
1,258,000
|
|
|
|
Common stock, shares issued |
|
|
560,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,722,717
|
|
|
|
|
|
|
Sale of common stock, net, shares |
|
432,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
679,000
|
560,000
|
432,000
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,720,914
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
$ 12.875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other offering expenses | $ |
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock |
|
|
|
|
|
432,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock | SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
19,488
|
|
|
|
|
|
|
|
|
|
June 2020 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion Of Preferred Stock Into Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
298,000,000
|
|
|
|
|
|
Warrant issued |
|
|
|
|
|
10,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds of common stock and warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,200,000
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net, shares |
678,745,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Declared | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10.50
|
|
|
|
|
|
|
Proceeds from the exercise of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,500,000
|
$ 0
|
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,000,000.0
|
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109.80%
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.50
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.45%
|
|
|
|
|
|
|
Allocation to common stock and warrants before issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,900,000
|
|
|
|
|
|
|
Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
180,000,000
|
|
|
|
|
Maximum | Original Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock equal value | $ |
|
|
|
|
|
|
|
|
|
$ 120,000,000
|
$ 120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum | SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22.00
|
|
|
|
|
|
|
Change in fair value of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
Maximum | DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35.50
|
|
|
|
|
|
|
Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000,000
|
|
|
|
|
Minimum | SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33.50
|
|
|
|
|
|
|
Minimum | DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 54.25
|
|
|
|
|
|
|
Series G Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity, Par or Stated Value Per Share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
Series F Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion Of Preferred Stock Into Common Stock |
|
|
|
|
1,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
251
|
882
|
|
|
|
|
Temporary equity preferred stock, shares authorized |
|
|
|
|
18,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, No Par Value | $ / shares |
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value $0.001 per share | $ |
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds of common stock and warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,000,000.0
|
|
|
|
|
|
|
Proceeds from issuance of equity securities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,000,000.0
|
|
|
|
|
|
|
Broker fees and related expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,900,000
|
|
|
|
|
|
|
Sale of common stock, net, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
17,000
|
|
|
|
|
Deemed dividend on convertible preferred stock | $ |
|
|
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
$ 500,000
|
|
|
|
|
|
Proceeds from issuance of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,700,000
|
$ 15,300,000
|
|
|
|
|
|
Series F Preferred Stock [Member] | June 2020 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued |
|
|
|
|
45,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series F Preferred Stock [Member] | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds allocated to the warrants based upon fair values | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,700,000
|
|
|
|
|
|
|
Deemed dividend on convertible preferred stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,700,000
|
|
|
|
|
Allocated to the warrants based upon fair values | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15,300,000
|
|
|
|
|
|
|
Series E Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity numbers of shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,565
|
|
|
|
Conversion Of Preferred Stock Into Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
278,240
|
|
|
|
Temporary equity net proceeds from conversion to common stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,000,000.0
|
|
|
|
Convertible preferred stock, shares issued and sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
69,565
|
|
|
|
Temporary equity preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Convertible Preferred Stock Converted to Common stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 278,260
|
|
|
|
Temporary Equity, Par or Stated Value Per Share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
Convertible preferred stock, shares issued upon conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
June 2022 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net, shares |
678,745,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering | $ |
$ 6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
$ 4.625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 2022 Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued |
726,660,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity raise of gross proceeds | $ |
$ 5,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
$ 4.624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series F Preferred Stock And July Two Thousand Twenty [Member] | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion Of Preferred Stock Into Common Stock |
|
|
|
|
1,800,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, net, shares |
|
|
|
|
18,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
$ 8.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility |
|
|
|
|
109.80%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
|
|
|
$ 11.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
0.27%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July Two Thousand Twenty Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued |
|
|
|
|
45,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance costs for common stock warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,600,000
|
|
|
|
|
|
|
Proceeds from the exercise of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 28,100,000
|
$ 3,900,000
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,300,000
|
|
|
|
|
|
|
Change in fair value of warrants | $ |
|
|
|
$ 5,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity, Fair Value Adjustment | $ |
|
|
|
$ 9,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July Two Thousand Twenty Warrants [Member] | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series F Preferred Stock And July Two Thousand Twenty Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock, shares issued and sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,480,000
|
|
|
|
|
|
Convertible Preferred Stock Converted to Common stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,122,500,000
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
$ 5.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility |
|
|
|
109.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
0.26%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price | $ / shares |
|
|
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,700,000
|
|
|
|
|
|
|
Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity numbers of shares sold |
|
|
|
|
|
|
432,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued |
|
|
|
|
|
|
10,800,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of equity securities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,600,000
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 12.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Series F Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock, shares issued upon conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
251
|
|
|
|
|
|
Private Placement | Series E Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity numbers of shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,565
|
|
|
|
Temporary equity net proceeds from conversion to common stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,000,000.0
|
|
|
|
|
|
|
|
|
Share price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 57.50
|
|
|
|
Private Placement | June 2022 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued |
1,405,405,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Noncontrolling Interest [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering | $ |
|
|
|
|
|
$ 6,900,000
|
$ 6,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration date |
|
|
|
|
|
Jun. 10, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
|
|
|
|
|
|
$ 16.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|